Zobrazeno 1 - 10
of 417
pro vyhledávání: '"J. Snijders"'
Autor:
F. H. B. Somhorst, R. van der Meer, M. Correa Anguita, R. Schadow, H. J. Snijders, M. de Goede, B. Kassenberg, P. Venderbosch, C. Taballione, J. P. Epping, H. H. van den Vlekkert, J. Timmerhuis, J. F. F. Bulmer, J. Lugani, I. A. Walmsley, P. W. H. Pinkse, J. Eisert, N. Walk, J. J. Renema
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)
Abstract One of the core questions of quantum physics is how to reconcile the unitary evolution of quantum states, which is information-preserving and time-reversible, with evolution following the second law of thermodynamics, which, in general, is n
Externí odkaz:
https://doaj.org/article/99415f699ec84e5186a8f0a9d36cf60c
Autor:
Steven H.J. Nagtegaal, Szabolcs David, Marielle E.P. Philippens, Tom J. Snijders, Alexander Leemans, Joost J.C. Verhoeff
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 26, Iss , Pp 35-41 (2021)
Background and purpose: The relation between radiotherapy (RT) dose to the brain and morphological changes in healthy tissue has seen recent increased interest. There already is evidence for changes in the cerebral cortex and white matter, as well as
Externí odkaz:
https://doaj.org/article/fc7352cc259343cf851e37be45f17143
Autor:
Pierre A. Robe, Matea Rados, Wim G. Spliet, Reinier G. Hoff, Peter Gosselaar, Marike L. D. Broekman, Martine J. van Zandvoort, Tatjana Seute, Tom J. Snijders
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundUntil 2015, Dutch guidelines recommended follow-up and biopsy rather than surgery as initial care for suspected low-grade gliomas (LGG). Given evidence that surgery could extend patient survival, our center stopped following this guideline
Externí odkaz:
https://doaj.org/article/271f3c8b99824b70b6e3a84c0a6ab328
Autor:
Emma van Kessel, Ewoud Schuit, Irene M. C. Huenges Wajer, Carla Ruis, Filip Y. F. L. De Vos, Joost J. C. Verhoeff, Tatjana Seute, Martine J. E. van Zandvoort, Pierre A. Robe, Tom J. Snijders
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Diffuse gliomas, which are at WHO grade II-IV, are progressive primary brain tumors with great variability in prognosis. Our aim was to investigate whether pre-operative cognitive functioning is of added value in survival prediction in th
Externí odkaz:
https://doaj.org/article/f5fe308b91034fba9bfa10e59f1b0199
Autor:
Zahra Shams, Wybe J. M. van der Kemp, Uzay Emir, Jan Willem Dankbaar, Tom J. Snijders, Filip Y. F. de Vos, Dennis W. J. Klomp, Jannie P. Wijnen, Evita C. Wiegers
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
The onco-metabolite 2-hydroxyglutarate (2HG), a biomarker of IDH-mutant gliomas, can be detected with 1H MR spectroscopy (1H-MRS). Recent studies showed measurements of 2HG at 7T with substantial gain in signal to noise ratio (SNR) and spectral resol
Externí odkaz:
https://doaj.org/article/fc9302a434e24c8686ae68b0af1a15f4
Autor:
Florien W Boele, Patricia W M den Otter, Jaap C Reijneveld, Philip C de Witt Hamer, Hinke F van Thuijl, Linda M C Lorenz, Pieter Wesseling, Frank J Lagerwaard, Martin J B Taphoorn, Mathilde C M Kouwenhoven, Tom J Snijders, Linda Douw, Martin Klein
Publikováno v:
Neuro-Oncology, 25(2), 351-364. Oxford University Press
Neuro-Oncology, 25(2), 351-364. OXFORD UNIV PRESS INC
Boele, F W, den Otter, P W M, Reijneveld, J C, de Witt Hamer, P C, van Thuijl, H F, Lorenz, L M C, Wesseling, P, Lagerwaard, F J, Taphoorn, M J B, Kouwenhoven, M C M, Snijders, T J, Douw, L & Klein, M 2023, ' Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers : A longitudinal study spanning two decades ', Neuro-Oncology, vol. 25, no. 2, pp. 351-364 . https://doi.org/10.1093/neuonc/noac185, https://doi.org/10.1093/neuonc/noac185
Neuro-Oncology, 25(2), 351-364. OXFORD UNIV PRESS INC
Boele, F W, den Otter, P W M, Reijneveld, J C, de Witt Hamer, P C, van Thuijl, H F, Lorenz, L M C, Wesseling, P, Lagerwaard, F J, Taphoorn, M J B, Kouwenhoven, M C M, Snijders, T J, Douw, L & Klein, M 2023, ' Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers : A longitudinal study spanning two decades ', Neuro-Oncology, vol. 25, no. 2, pp. 351-364 . https://doi.org/10.1093/neuonc/noac185, https://doi.org/10.1093/neuonc/noac185
Background While patients with diffuse low-grade glioma (LGG) often survive for years, there is a risk of tumor progression which may impact patients’ long-term health-related quality of life (HRQOL) and neurocognitive functioning (NCF). We present
Autor:
Maria Alieva, Andreia S. Margarido, Tamara Wieles, Erik R. Abels, Burcin Colak, Carla Boquetale, Herke Jan Noordmans, Tom J. Snijders, Marike L. Broekman, Jacco van Rheenen
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Abstract Although biopsies and tumor resection are prognostically beneficial for glioblastomas (GBM), potential negative effects have also been suggested. Here, using retrospective study of patients and intravital imaging of mice, we identify some of
Externí odkaz:
https://doaj.org/article/870adc24b20d4709945c1f69dfd3f0c7
Autor:
Arthur T. J. van der Boog, Matea Rados, Annemarie Akkermans, Jan Willem Dankbaar, Ufuk Kizilates, Tom J. Snijders, Jeroen Hendrikse, Joost J. C. Verhoeff, Reinier G. Hoff, Pierre A. Robe
Publikováno v:
Neurosurgery. 92:125-136
Autor:
Stephanie B. H. Gumbs, Raphael Kübler, Lavina Gharu, Pauline J. Schipper, Anne L. Borst, Gijsje J. L. J. Snijders, Paul R. Ormel, Amber Berdenis van Berlekom, Annemarie M. J. Wensing, Lot D. de Witte, Monique Nijhuis
Publikováno v:
Journal of NeuroVirology. 28:64-91
HIV persistence in the CNS despite antiretroviral therapy may cause neurological disorders and poses a critical challenge for HIV cure. Understanding the pathobiology of HIV-infected microglia, the main viral CNS reservoir, is imperative. Here, we pr
Autor:
Mark P van Opijnen, Filip Y F de Vos, Rob J A Nabuurs, Tom J Snijders, Rishi D S Nandoe Tewarie, Walter Taal, Joost J C Verhoeff, Jacobus J M van der Hoeven, Marike L D Broekman
Publikováno v:
Neuro-Oncology Practice.
Background Despite current best treatment options, a glioblastoma almost inevitably recurs after primary treatment. However, in the absence of clear evidence, current guidelines on recurrent glioblastoma are not well-defined. Re-resection is one of t